Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA) (2014)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- Subjects: ARTERIOSCLEROSE CORONÁRIA; CÁLCIO (METABOLISMO); DOENÇAS CARDIOVASCULARES; FATORES DE RISCO; ESTUDOS LONGITUDINAIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 130, n. suppl. 1, res. 15615, nov. 2014
- Conference titles: Scientific Sessions 2014
-
ABNT
NASIR, Khurram et al. Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. Dallas: Hospital Universitário, Universidade de São Paulo. . Acesso em: 28 jan. 2026. , 2014 -
APA
Nasir, K., Bittencourt, M. S., Blaha, M. J., Budoff, M. J., Blankstein, R., Agatston, A., et al. (2014). Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. Dallas: Hospital Universitário, Universidade de São Paulo. -
NLM
Nasir K, Bittencourt MS, Blaha MJ, Budoff MJ, Blankstein R, Agatston A, Sibley CT, Shaw LJ, Blumenthal R, Krumholz HM. Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2014 ; no 2014( suppl. 1):[citado 2026 jan. 28 ] -
Vancouver
Nasir K, Bittencourt MS, Blaha MJ, Budoff MJ, Blankstein R, Agatston A, Sibley CT, Shaw LJ, Blumenthal R, Krumholz HM. Eligibility for lipid lowering therapy based on AHA/ACC risk score, coronary artery calcification, and CVD events- national implications for the appropriate use of preventive pharmacotherapy: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2014 ; no 2014( suppl. 1):[citado 2026 jan. 28 ] - Incremental prognostic value of coronary artery disease and renal function on the prediction of cardiovascular events of patients evaluated by coronary computed tomography: the partners registry
- Changes in F18-flurodeoxyglucose uptake on serial cardiac positron emission tomography and left ventricular ejection fraction in patients with cardiac sarcoidosis
- Physical activity levels and hepatic steatosis: a longitudinal follow-up study in adults
- In vitro validation of coronary CT angiography for the evaluation of complex lesions
- Can coronary computed tomography angiography be the complete roadmap for chronic total occlusion management? [Editorial]
- Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment
- One year follow up of ambulatory electrocardiographic variables of patients with severe coronary artery disease undergoing coronary artery bypass graft surgery plus intramyocardial bone marrow cell injection
- Left main coronary artery disease is correlated to the clinical characteristics of stable coronary artery disease patients: a study ajusted to the coronary atherosclerotic burden
- Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia
- Coronary artery bypass surgery in diffuse advanced coronary artery disease: 1-year clinical and angiographic results
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
